Bio Protocol vs Spark — how do they compare? Bio Protocol trades at Rp513.51 (market cap Rp1,15T, Rp260,42M 24h volume), while Spark trades at Rp314.85 (market cap Rp979,11M, Rp230,69M 24h volume). The key difference: Bio Protocol is far larger — about 1174.5× Spark's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 3,1B / 10B SPK (31%) for Spark. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Spark for 11 Days on average.
| BIO | SPK | |
|---|---|---|
Market Cap | Rp1,15T | Rp979,11M |
Volume (24h) | Rp260,42M | Rp230,69M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 3,1B / 10B SPK (31%) |
Typical Hold Time | 16 Days | 11 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Spark (SPK) is currently trading at Rp318.94 with a market cap of Rp972.92 million, showing a bearish technical trend as indicated by moving averages. The token has a circulating supply of 3.1 million out of a maximum 10 million, with a circulation rate of 31%. Recent on-chain data indicates an average hold time of 11 days. No major protocol updates or ecosystem developments have been reported recently, keeping fundamental activity subdued.
Overall outlook remains cautious due to bearish technical signals and limited fundamental catalysts. Key opportunities include potential rebounds from support levels like Rp297, while major risks involve low liquidity and high volatility typical of small-cap cryptocurrencies. Investors should monitor exchange volume and broader market sentiment for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Spark is an on-chain capital allocator that has deployed $3.86 billion across decentralized finance (DeFi), centralized finance (CeFi), and real-world assets (RWA). It enhances capital efficiency on a large scale by automatically adjusting allocations based on market conditions while maintaining a conservative risk profile. Spark tackles inefficiencies in DeFi, such as fragmented liquidity, unstable yields, and idle stablecoin capital. It provides deep, consistent liquidity and offers programmable, fee-free income through products like sUSDS and sUSDC.
Read more on SPK →